Evaluation of the Rationality of Appropriate Doses of Corticosteroid Drugs in Patients With Nephrotic Syndrome in Hospitals
DOI:
https://doi.org/10.52221/jurkes.v9i2.342Keywords:
nephrotic syndrom, therapy corticosteroids, right doseAbstract
Nephrotic syndrome is a kidney disease in which symptoms include massive proteinuria, hypoalbuminemia, edema, and hyperlipidemia. Nephrotic syndrome has first-line therapy using corticosteroids. The purpose of this study was to determine the accuracy of the dose in patients with nephrotic syndrome. The method used in this study is a qualitative descriptive method of retrospective data acquisition by taking a sample population of nephrotic syndrome patients at the Outpatient Installation of General Hospital of Ciamis District Period January-July 2020. Descriptive analysis includes the accuracy of the dose guided by the management of Kidney Disease: Improving Global Outcomes (KDIGO) which is presented in the form of tables and narratives. The results of this study indicate that the ratio between men and women is 3:1 with those under 15 years old. There were 18 cases of nephrotic syndrome using corticosteroid therapy. The most widely used corticosteroids were methylprednisolone 61.1% (11 patients) and prednisone 38.9% (7 patients). The use of the dose in 18 cases of nephrotic syndrome was stated to be the right dose (100%) and in accordance with the management recommendations.
References
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Susan Sintia Ramdhani, Nurhidayati Harun, Tina Marlina
This work is licensed under a Creative Commons Attribution 4.0 International License.